Ocular Therapeutix, Inc

(NASDAQ:OCUL)

Latest On Ocular Therapeutix, Inc (OCUL):

Date/Time Type Description Signal Details
2023-05-18 23:34 ESTNewsOcular Therapeutix: I Still Don't See The NeedN/A
2023-05-09 02:50 ESTNewsOcular Therapeutix GAAP EPS of -$0.39 misses by $0.12, revenue of $13.37M misses by $0.73MN/A
2023-05-09 02:50 ESTNewsOcular Therapeutix, Inc. (OCUL) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 01:03 ESTNewsOcular Therapeutix Q1 2023 Earnings PreviewN/A
2023-03-07 22:48 ESTNewsOcular Therapeutix stock rises after posting Q4 results beat, strong guidanceN/A
2023-03-07 08:01 ESTNewsOcular Therapeutix, Inc. (OCUL) Q4 2022 Earnings Call TranscriptN/A
2023-03-06 17:33 ESTNewsOcular Therapeutix Q4 GAAP EPS, revenue beats, guidance below consensusN/A
2023-03-06 02:44 ESTNewsOcular Therapeutix Q4 2022 Earnings PreviewN/A
2023-03-04 00:55 ESTNewsOcular Therapeutix: A Promising Turnaround PlayN/A
2023-02-14 11:58 ESTNewsNext Round Of Financing Will Be Transformational For Ocular TherapeutixN/A
2023-02-13 09:49 ESTNewsOcular stock rises ~15% as eye drug implant shows promise in ongoing phase 1 trialN/A
2023-02-12 21:43 ESTNewsOcular Therapeutix: A 'Buy' On Maturing Wet AMD DataN/A
2022-12-12 00:53 ESTNewsOcular Therapeutix: Good Potential, But Not That Good An ExecutionN/A
2022-11-08 16:55 ESTNewsOcular falls 12% as eye therapy Dextenza Q3 sales decline, cuts FY22 outlookN/A
2022-11-08 16:55 ESTNewsOcular Therapeutix hits 52-week low after slashing revenue guidanceN/A
2022-11-07 22:46 ESTNewsOcular Therapeutix GAAP EPS of -$0.31 misses by $0.07, revenue of $11.97M misses by $2.3MN/A
2022-11-07 22:46 ESTNewsOcular Therapeutix, Inc. (OCUL) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 06:22 ESTNewsOcular Therapeutix Q3 2022 Earnings PreviewN/A
2022-09-27 15:05 ESTNewsOcular stock rises as eye drug implant OTX-TKI shows promise in vision disorder in trialN/A
2022-08-22 02:45 ESTNewsOcular Therapeutix: Dextenza Sales Accelerating And Near-Term Catalyst ApproachingN/A
2022-08-15 19:39 ESTNewsOcular Therapeutix: Trading Ahead Of An Underappreciated Catalyst EventN/A
2022-08-09 06:07 ESTNewsOcular Therapeutix GAAP EPS of -$0.25 misses by $0.02, revenue of $12.26M misses by $1.99MN/A
2022-08-09 06:07 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 05:34 ESTNewsOcular Therapeutix Q2 2022 Earnings PreviewN/A
2022-05-10 11:19 ESTNewsOcular Therapeutix GAAP EPS of -$0.22 beats by $0.03, revenue of $13.19M misses by $0.77MN/A
2022-05-10 11:18 ESTNewsOcular Therapeutix's (OCUL) CEO Antony Mattessich on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-07 05:46 ESTNewsOcular Therapeutix Q1 2022 Earnings PreviewN/A
2022-03-29 07:01 ESTNewsOcular Therapeutix: A Follow-UpN/A
2022-03-08 17:48 ESTNewsOcular Therapeutix: Transformative Year Ahead Full Of Important MilestonesN/A
2022-03-01 10:49 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 16:33 ESTNewsOcular Therapeutix GAAP EPS of -$0.23 in-line, revenue of $12.31M misses by $2.13MN/A
2022-02-27 21:16 ESTNewsOcular Therapeutix Q4 2021 Earnings PreviewN/A
2022-01-19 15:59 ESTNewsOcular Therapeutix owner buys 50,000 shares worth ~$300KN/A
2022-01-19 00:54 ESTNewsAffaMed Therapeutics begins dosing in China trial of DEXTENZA to treat ocular inflammationN/A
2022-01-08 01:34 ESTNewsOcular Therapeutix: Shaken By Covid, Perfectly Positioned For Long-Term GainsN/A
2021-12-12 09:46 ESTNewsHighlighting Ocular TherapeutixN/A
2021-12-10 00:37 ESTNewsOcular Therapeutix trades high on director acquiring 60.9K sharesN/A
2021-12-08 10:52 ESTNewsWarning: OCUL is at high risk of performing badlyN/A
2021-12-06 20:03 ESTNewsOcular Therapeutix reports positive OTX-DED data in mid-stage dry eye disease studyN/A
2021-11-09 14:12 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 16:27 ESTNewsOcular Therapeutix EPS beats by $0.04, misses on revenueN/A
2021-11-07 19:57 ESTNewsOcular Therapeutix Q3 2021 Earnings PreviewN/A
2021-10-24 05:07 ESTNewsMeiraGTx, Aurinia among healthcare gainers this week; Jasper slips after twofold riseN/A
2021-10-22 16:55 ESTNewsOcular Therapeutix posts topline results from mid-stage OTX-CSI dry eye disease trialN/A
2021-10-11 15:36 ESTNewsOcular Therapeutix gains on FDA approval of DEXTENZA for new indicationN/A
2021-10-11 15:36 ESTNewsOyster Point benefits from Ocular sNDA approval; shares up 13%N/A
2021-08-10 09:07 ESTNewsOcular Therapeutix EPS misses by $0.05, beats on revenueN/A
2021-08-10 09:06 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-09 12:28 ESTNewsOcular Therapeutix: Why I'm Buying The DipN/A
2021-08-06 08:09 ESTNewsOcular Therapeutix and Regeneron scrap collaboration agreementN/A

About Ocular Therapeutix, Inc (OCUL):

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant administered by the fine-gauge needle that is in phase 1 clinical trial for the treatment of wet age-related macular degeneration; OTX-TIC, a travoprost intracameral implant, which is in phase 1 clinical trial for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that is in phase 2 clinical trial for the chronic treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trial for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company is involved in the development of OTX-AFS, an aflibercept suprachoroidal injection for the treatment of retinal diseases. It has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

OCUL Quotes by TradingView

See Advanced Chart

General

  • Name Ocular Therapeutix, Inc
  • Symbol OCUL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 181
  • Fiscal Year EndDecember
  • IPO Date2014-07-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.ocutx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 91.26
  • Price/Book (Most Recent Quarter) 124.04
  • Enterprise Value Revenue 87.16
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.69
  • Next Year EPS Estimate -$0.25
  • Next Quarter EPS Estimate -$0.17
  • Operating Margin -361%
  • Return on Assets -23%
  • Return on Equity -430%
  • Revenue 17.4 million
  • Earnings Per Share -$1.79
  • Revenue Per Share $0.29
  • Gross Profit -13374000
  • Quarterly Earnings Growth 225.8%
View More

Highlights

  • Market Capitalization 1.55 billion
  • EBITDA -71014000
  • PE Ratio -8.05
  • Analyst Target Price $25.5
  • Book Value Per Share $1.00
View More

Share Statistics

  • Shares Outstanding 76.07 million
  • Shares Float 66.88 million
  • % Held by Insiders 466%
  • % Held by Institutions 55.42%
  • Shares Short 5.07 million
  • Shares Short Prior Month 4.75 million
  • Short Ratio 4.88
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.19
  • 52 Week High $24.3
  • 52 Week Low $4.09
  • 50 Day Moving Average 19.01
  • 200 Day Moving Average 15.53
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ocular Therapeutix, Inc (OCUL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ocular Therapeutix, Inc (OCUL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$7.35 million-$0.23-$0.17-35.82%
2020-09-302020-11-05$5.88 million-$0.19-$0.2522.98%
2020-06-302020-08-07$N/A-$0.64-$0.32-97.96%
2020-03-312020-05-08$2.61 million-$0.41-$0.5017.17%
2019-12-312020-03-12$2.26 million-$0.53-$0.42-26.19%
2019-09-302019-11-12$829000-$0.45-$0.462.17%
2019-06-302019-08-07$650000-$0.57-$0.48-17.94%
2019-03-312019-05-10$492000-$0.41-$0.421.2%
2018-12-312019-03-07$504000-$0.42-$0.38-9.38%
2018-09-302018-11-07$498000-$0.38-$0.37-2.7%
2018-06-302018-08-07$648000-$0.37-$0.381.33%
2018-03-312018-05-08$340000-$0.40-$0.412.44%
2017-12-312018-03-08$487000-$0.44-$0.5316.98%
2017-09-302017-11-07$523000-$0.54-$0.53-1.89%
2017-06-302017-08-08$438000-$0.64-$0.57-11.5%
2017-03-312017-05-05$475000-$0.58-$0.48-20.01%
2016-12-312017-03-10$511000-$0.52-$0.46-13.66%
2016-09-302016-11-09$477000-$0.39-$0.5021.61%
2016-06-302016-08-09$441000-$0.46-$0.495.49%
2016-03-312016-05-10$458000-$0.44-$0.43-1.95%
2015-12-312016-03-10$436000-$0.43-$0.479.15%
2015-09-302015-11-10$429000-$0.47-$0.38-23.68%
2015-06-302015-08-10$459000-$0.45-$0.33-36.36%
2015-03-312015-05-15$426000-$0.35-$0.3910.26%
2014-12-312015-03-10$505000-$0.37-$0.382.63%
2014-09-302014-11-12$143000-$0.48-$0.43-11.63%
2014-06-302014-08-29$97000-$2.10

Ocular Therapeutix, Inc (OCUL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ocular Therapeutix, Inc (OCUL) Chart:

Ocular Therapeutix, Inc (OCUL) News:

Below you will find a list of latest news for Ocular Therapeutix, Inc (OCUL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ocular Therapeutix, Inc (OCUL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0560.23TRUE00
2024-05-1750.11CALL94 45186.91FALSE-0.14-0.56
2024-05-177.50.03CALL3 1364137.76FALSE0.030
2024-05-17100.15CALL0 11020FALSE00
2024-05-1712.50.13CALL0 770FALSE00
2024-05-17150.05CALL0 1210FALSE00
2024-05-1717.50CALL0 00FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-172.50.05PUT0 5020FALSE00
2024-05-1750.9PUT540 205687.69TRUE0.320.55
2024-05-177.53.3PUT1 520TRUE0.520.19
2024-05-17105.3PUT0 3489.23TRUE00
2024-05-1712.53.1PUT0 0475.53TRUE00
2024-05-17150PUT0 0567.31TRUE00
2024-05-1717.50PUT0 0599.42TRUE00
2024-05-17200PUT0 0626.42TRUE00
2024-06-2111.4CALL0 40592.14TRUE00
2024-06-2129.1CALL0 16413.19TRUE00
2024-06-2131.3CALL2 18779.84TRUE-0.75-0.37
2024-06-2140.75CALL2 7233.45TRUE-0.1-0.12
2024-06-2150.24CALL100 16575.34FALSE-0.26-0.52
2024-06-2160.15CALL5 26272.52FALSE0.050.5
2024-06-217.50.05CALL0 661116.19FALSE00
2024-06-21100.05CALL2 401125.27FALSE0.050
2024-06-2112.50.2CALL0 3550FALSE00
2024-06-21150.35CALL0 1140FALSE00
2024-06-2117.50.05CALL1 559181.68FALSE00
2024-06-21200.3CALL0 410FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2120.1PUT0 110FALSE00
2024-06-2130.15PUT0 1000FALSE00
2024-06-2140.35PUT6 10571.6FALSE0.10.4
2024-06-2150.82PUT3 126765.83TRUE0.120.17
2024-06-2160.75PUT0 104792.75TRUE00
2024-06-217.52.95PUT0 4992105.67TRUE00
2024-06-21102.5PUT0 239223.64TRUE00
2024-06-2112.53.61PUT0 0337.57TRUE00
2024-06-21150PUT0 0362.97TRUE00
2024-06-2117.50PUT0 0360.01TRUE00
2024-06-21200PUT0 0385.62TRUE00
2024-09-202.52.6CALL0 16274.87TRUE00
2024-09-2050.73CALL5 15486.61FALSE-0.07-0.09
2024-09-205.50CALL0 00FALSE00
2024-09-207.50.2CALL2 18581.37FALSE-0.14-0.41
2024-09-20100.1CALL1 24988.25FALSE0.10
2024-09-2012.50.1CALL0 2960FALSE00
2024-09-20150.2CALL0 50FALSE00
2024-09-2017.50.15CALL0 40FALSE00
2024-09-20200.52CALL0 350FALSE00
2024-09-202.50PUT0 086.8FALSE00
2024-09-2050.65PUT0 12783.48TRUE00
2024-09-205.50PUT0 00TRUE00
2024-09-207.52.7PUT0 114581.3TRUE00
2024-09-20103.1PUT0 5176.47TRUE00
2024-09-2012.53.8PUT0 0198.05TRUE00
2024-09-20150PUT0 0210.19TRUE00
2024-09-2017.50PUT0 0229.37TRUE00
2024-09-20200PUT0 0261.19TRUE00
2024-12-202.52.15CALL4 20100.57TRUE-0.55-0.2
2024-12-2051.3CALL0 30245.07FALSE00
2024-12-207.50.5CALL20 089.48FALSE0.50
2024-12-20100CALL0 092.2FALSE00
2024-12-2012.50CALL0 0100.69FALSE00
2024-12-20150CALL0 00FALSE00
2024-12-202.50PUT0 0111.35FALSE00
2024-12-2050PUT0 088.65TRUE00
2024-12-207.53.25PUT0 1004172.16TRUE00
2024-12-20100PUT0 0132.34TRUE00
2024-12-2012.50PUT0 0169.84TRUE00
2024-12-20150PUT0 0188.07TRUE00
2025-01-1720CALL0 00TRUE00
2025-01-172.52.2CALL0 6306.01TRUE00
2025-01-1732.45CALL0 45219.75TRUE00
2025-01-173.57.6CALL0 30232.88TRUE00
2025-01-1742.95CALL0 7225.37TRUE00
2025-01-174.51.5CALL10 5111.72FALSE-0.25-0.14
2025-01-1751.53CALL0 1101231.51FALSE00
2025-01-175.51.5CALL0 6241.13FALSE00
2025-01-1770.95CALL0 22982.94FALSE00
2025-01-17100.25CALL0 17786.96FALSE00
2025-01-1712.50.24CALL0 57480.06FALSE00
2025-01-17152.05CALL0 340FALSE00
2025-01-1717.50.15CALL0 720FALSE00
2025-01-17200.4CALL0 330FALSE00
2025-01-1720PUT0 00FALSE00
2025-01-172.50.15PUT0 6990.15FALSE00
2025-01-1730.5PUT1 47087.42FALSE0.50
2025-01-173.50.6PUT0 20286.14FALSE00
2025-01-1740.85PUT0 13861FALSE00
2025-01-174.51.03PUT0 11196.53TRUE00
2025-01-1751.26PUT0 20277.5TRUE00
2025-01-175.50.68PUT0 53155.24TRUE00
2025-01-1772.45PUT0 208156.32TRUE00
2025-01-17102.81PUT0 6122.81TRUE00
2025-01-1712.56.5PUT0 0140.01TRUE00
2025-01-17150PUT0 0179.9TRUE00
2025-01-1717.50PUT0 0187.95TRUE00
2025-01-17200PUT0 0201.76TRUE00
2026-01-162.52.76CALL5 6106.82TRUE2.760
2026-01-1633.8CALL0 30TRUE00
2026-01-163.57.6CALL0 340TRUE00
2026-01-1646.2CALL0 140TRUE00
2026-01-164.55.6CALL0 130FALSE00
2026-01-1652.7CALL0 320FALSE00
2026-01-165.53.5CALL0 90FALSE00
2026-01-1671.5CALL5 4695.15FALSE-0.4-0.21
2026-01-16101.2CALL0 241165.93FALSE00
2026-01-1612.51.05CALL0 482194.99FALSE00
2026-01-16152.8CALL1 618196.6FALSE22.5
2026-01-1617.50CALL0 00FALSE00
2026-01-16200.55CALL0 40FALSE00
2026-01-162.50.55PUT0 1486.58FALSE00
2026-01-1630PUT0 091.19FALSE00
2026-01-163.50PUT0 0101.04FALSE00
2026-01-1640PUT0 091.9FALSE00
2026-01-164.50PUT0 089.91TRUE00
2026-01-1652.21PUT0 382.24TRUE00
2026-01-165.50PUT0 070.98TRUE00
2026-01-1672.9PUT0 2296.81TRUE00
2026-01-16105.3PUT0 8184.88TRUE00
2026-01-1612.55.5PUT0 1110.6TRUE00
2026-01-16150PUT0 0123.9TRUE00
2026-01-1617.59.5PUT0 1127.92TRUE00
2026-01-16200PUT0 0135.85TRUE00

Latest OCUL Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$3.57
Jun 13, 2022 7:59 PM EST18$3.565
Jun 13, 2022 7:59 PM EST100$3.57
Jun 13, 2022 7:59 PM EST5$3.565
Jun 13, 2022 7:59 PM EST2$3.565

Ocular Therapeutix, Inc (OCUL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm
2019-02-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1393434/000000000019001625/0000000000-19-001625-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1393434/000000000019006740/0000000000-19-006740-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000005341719000053/0000053417-19-000053-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000021545719006851/0000215457-19-006851-index.htm
2018-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000031506618002543/0000315066-18-002543-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000031506619001221/0000315066-19-001221-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000083423720006050/0000834237-20-006050-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000083423720009555/0000834237-20-009555-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000008/0000893838-19-000008-index.htm
2019-03-04SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000010/0000893838-19-000010-index.htm
2019-04-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000011/0000893838-19-000011-index.htm
2019-05-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000090514819000611/0000905148-19-000611-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000090514820000304/0000905148-20-000304-index.htm
2018-12-28S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1393434/000104746918007791/0001047469-18-007791-index.htm
2019-04-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1393434/000104746919001837/0001047469-19-001837-index.htm
2019-04-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746919002010/0001047469-19-002010-index.htm
2019-04-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1393434/000104746919002765/0001047469-19-002765-index.htm
2020-05-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746920003131/0001047469-20-003131-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746920003152/0001047469-20-003152-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465918066652/0001104659-18-066652-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm
2018-12-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465918075138/0001104659-18-075138-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000887/0001104659-19-000887-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000889/0001104659-19-000889-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000890/0001104659-19-000890-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000891/0001104659-19-000891-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000892/0001104659-19-000892-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000894/0001104659-19-000894-index.htm
2019-01-16DEL AMDelaying amendmenthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919002007/0001104659-19-002007-index.htm
2019-02-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1393434/000110465919006823/0001104659-19-006823-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919009429/0001104659-19-009429-index.htm
2019-02-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919009989/0001104659-19-009989-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919013380/0001104659-19-013380-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919013389/0001104659-19-013389-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm
2019-03-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016897/0001104659-19-016897-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016898/0001104659-19-016898-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016981/0001104659-19-016981-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919020175/0001104659-19-020175-index.htm
2019-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919023120/0001104659-19-023120-index.htm
2019-04-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1393434/000110465919023739/0001104659-19-023739-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919024896/0001104659-19-024896-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919028431/0001104659-19-028431-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919029753/0001104659-19-029753-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919030555/0001104659-19-030555-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919032737/0001104659-19-032737-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919033292/0001104659-19-033292-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034285/0001104659-19-034285-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm
2019-06-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035409/0001104659-19-035409-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035410/0001104659-19-035410-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035411/0001104659-19-035411-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035412/0001104659-19-035412-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035413/0001104659-19-035413-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035414/0001104659-19-035414-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035515/0001104659-19-035515-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036832/0001104659-19-036832-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919039304/0001104659-19-039304-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919039308/0001104659-19-039308-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919044532/0001104659-19-044532-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919051114/0001104659-19-051114-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919061710/0001104659-19-061710-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919062030/0001104659-19-062030-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009939/0001104659-20-009939-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009941/0001104659-20-009941-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009943/0001104659-20-009943-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009945/0001104659-20-009945-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920012235/0001104659-20-012235-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920021085/0001104659-20-021085-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920028268/0001104659-20-028268-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920032464/0001104659-20-032464-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920032495/0001104659-20-032495-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920045708/0001104659-20-045708-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920051935/0001104659-20-051935-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920058381/0001104659-20-058381-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920061664/0001104659-20-061664-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920065123/0001104659-20-065123-index.htm
2020-06-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000110465920073398/0001104659-20-073398-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077440/0001104659-20-077440-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077441/0001104659-20-077441-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077444/0001104659-20-077444-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077446/0001104659-20-077446-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077448/0001104659-20-077448-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077449/0001104659-20-077449-index.htm
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920080918/0001104659-20-080918-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920083953/0001104659-20-083953-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920084290/0001104659-20-084290-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920091724/0001104659-20-091724-index.htm
2020-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920108898/0001104659-20-108898-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920112646/0001104659-20-112646-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920112885/0001104659-20-112885-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920114553/0001104659-20-114553-index.htm
2020-10-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000110465920114581/0001104659-20-114581-index.htm
2020-10-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000110465920114906/0001104659-20-114906-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920115475/0001104659-20-115475-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920119750/0001104659-20-119750-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920121801/0001104659-20-121801-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000113777419000037/0001137774-19-000037-index.htm
2020-03-25SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000114036120006856/0001140361-20-006856-index.htm
2020-05-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000114036120012177/0001140361-20-012177-index.htm
2019-03-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000139343419000001/0001393434-19-000001-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000141057818000569/0001410578-18-000569-index.htm
2019-05-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000149315219006391/0001493152-19-006391-index.htm
2019-12-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315219019793/0001493152-19-019793-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000453/0001493152-20-000453-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220005795/0001493152-20-005795-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837018008793/0001558370-18-008793-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1393434/000155837019001659/0001558370-19-001659-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1393434/000155837019003296/0001558370-19-003296-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000155837019003299/0001558370-19-003299-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019004776/0001558370-19-004776-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019007462/0001558370-19-007462-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019010684/0001558370-19-010684-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1393434/000155837020002537/0001558370-20-002537-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1393434/000155837020004640/0001558370-20-004640-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000155837020004644/0001558370-20-004644-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020005871/0001558370-20-005871-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020009817/0001558370-20-009817-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020012870/0001558370-20-012870-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761919006040/0001567619-19-006040-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm
2019-02-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1393434/999999999519000194/9999999995-19-000194-index.htm
2019-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1393434/999999999519000902/9999999995-19-000902-index.htm
2019-10-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1393434/999999999719007342/9999999997-19-007342-index.htm

Ocular Therapeutix, Inc (OCUL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ocular Therapeutix, Inc (OCUL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 466%
Institutional Ownership: 5542%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-10Kevin F. HanleyOfficerBuy10,000.005.6056,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm
2019-03-13RICHARD L MD LINDSTROMDirectorBuy56,441.004.33244,389.53100,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm
2019-06-07Amarpreet SawhneyChairman of the BoardBuy65,468.003.02197,713.361,056,031.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm
2019-03-15Michael H. GoldsteinChief Medical OfficerBuy10,000.004.1541,500.0013,686.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm
2018-12-14Kevin F. HanleyOfficerBuy10,000.005.5055,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm
2019-12-30Opaleye Management Inc.10% Share HolderBuy5,000.003.9719,852.50207,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2019-03-15Jeffrey S. HeierDirectorBuy24,000.004.1599,600.0024,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm
2019-06-14Donald NotmanChief Financial OfficerBuy2,500.004.3310,825.0024,049.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm
2019-05-28Michael H. GoldsteinChief Medical OfficerBuy12,000.002.5130,120.0025,686.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm
2020-03-13SUMMER ROAD LLC10% Share HolderBuy210,800.004.63975,982.924,015,588.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2020-03-16SUMMER ROAD LLC10% Share HolderBuy194,262.004.16807,216.894,209,850.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2018-12-06Daniel M BollagOfficerBuy17,400.005.76100,224.0042,100.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm
2019-06-14Leslie J. WilliamsDirectorBuy4,500.004.4019,800.004,500.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm
2020-03-17SUMMER ROAD LLC10% Share HolderBuy550,000.004.662,562,890.004,759,850.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2019-12-30Opaleye Management Inc.10% Share HolderBuy15,000.003.9759,557.504,903,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2020-01-02Opaleye Management Inc.10% Share HolderBuy15,000.003.9058,507.504,918,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm
2020-03-18SUMMER ROAD LLC10% Share HolderBuy344,938.004.621,594,199.955,104,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-19SUMMER ROAD LLC10% Share HolderBuy40,900.004.63189,223.855,145,688.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-20SUMMER ROAD LLC10% Share HolderBuy9,100.004.5241,119.265,154,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-03-23SUMMER ROAD LLC10% Share HolderBuy64,948.004.66302,365.415,219,736.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-03-24SUMMER ROAD LLC10% Share HolderBuy35,052.004.87170,713.765,254,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-05-19SUMMER ROAD LLC10% Share HolderBuy363,636.005.501,999,998.005,618,424.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm
2020-10-16SUMMER ROAD LLC10% Share HolderBuy437.0010.484,579.765,618,861.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm
2019-06-04Amarpreet SawhneyChairman of the BoardBuy12,928.002.9237,749.76898,711.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-05Amarpreet SawhneyChairman of the BoardBuy32,852.002.9195,599.32931,563.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-06Antony C. MattessichPresident & CEOBuy40,000.002.81112,400.0097,900.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm
2019-06-06Amarpreet SawhneyChairman of the BoardBuy59,000.002.80165,200.00990,563.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm